Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols

Urology

Volumn 81, Issue 4, 2013, Pages 837-843

  Müller, Georg ^a   Bonkat, Gernot ^a   Rieken, Malte ^a   Wyler, Stephen F ^a   Bubendorf, Lukas ^b   Püschel, Heike ^a   Gasser, Thomas C ^a   Bachmann, Alexander ^a   Rentsch, Cyrill A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; DISEASE SURVEILLANCE; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR BIOPSY;

EID: 84875520423     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.10.068     Document Type: Article

References (22)

1. P.J. Bastian, B.H. Carter, and A. Bjartell Insignificant prostate cancer and active surveillance: from definition to clinical implications Eur Urol 55 2009 1321 1330
2. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
3. R.C. van den Bergh, S. Roemeling, and M.J. Roobol Prospective validation of active surveillance in prostate cancer: the PRIAS study Eur Urol 52 2007 1560 1563
4. N. Suardi, U. Capitanio, and F.K. Chun Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features Cancer 113 2008 2068 2072
5. B. Guillonneau, and G. Vallancien Laparoscopic radical prostatectomy: the Montsouris technique J Urol 163 2000 1643 1649
6. J.U. Stolzenburg, M. Do, and H. Pfeiffer The endoscopic extraperitoneal radical prostatectomy (EERPE): technique and initial experience World J Urol 20 2002 48 55
7. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th ed 2002 Springer New York
8. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 2005 1228 1242
9. P.J. Bastian, L.A. Mangold, and J.I. Epstein Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis Cancer 101 2004 2001 2005
10. S.E. Lee, D.S. Kim, and W.K. Lee Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men BJU Int 105 2010 1526 1530
11. C. Jeldres, N. Suardi, and J. Walz Validation of the contemporary Epstein criteria for insignificant prostate cancer in European men Eur Urol 54 2008 1306 1313
12. S.F. Oon, R.W. Watson, and J.J. O'Leary Epstein criteria for insignificant prostate cancer BJU Int 108 2011 518 525
13. R.C. van den Bergh, E.W. Steyerberg, and A. Khatami Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116 2010 1281 1290
14. N. Suardi, A. Briganti, and A. Gallina Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer BJU Int 105 2010 1548 1552
15. K. Eichler, S. Hempel, and J. Wilby Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review J Urol 175 2006 1605 1612
16. J. Donovan, F. Hamdy, and D. Neal Prostate testing for cancer and treatment (ProtecT) feasibility study Health Technol Assess 7 2003 1 88
17. U. Capitanio, P.I. Karakiewicz, and L. Valiquette Biopsy core number represents one of foremost predictors of clinically significant Gleason sum upgrading in patients with low-risk prostate cancer Urology 73 2009 1087 1091
18. R. Abouassaly, B.R. Lane, and J.S. Jones Staging saturation biopsy in patients with prostate cancer on active surveillance protocol Urology 71 2008 573 577
19. G. Ploussard, E. Xylinas, and L. Salomon The role of biopsy core number in selecting prostate cancer patients for active surveillance Eur Urol 56 2009 891 898
20. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
21. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
22. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439